Cargando…

Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation

PURPOSE: Exploring the molecular mechanisms of lung adenocarcinoma (LUAD) is beneficial for developing new therapeutic strategies and predicting prognosis. This study was performed to select core genes related to LUAD and to analyze their prognostic value. METHODS: Microarray datasets from the GEO (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Huan, Hang, Qingqing, Shen, Dijian, Zhang, Yibi, Chen, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117659/ https://www.ncbi.nlm.nih.gov/pubmed/33980221 http://dx.doi.org/10.1186/s12935-021-01933-9

Ejemplares similares

High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis
por: Deng, Huan, et al.
Publicado: (2021)

Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis
por: Sun, Jian, et al.
Publicado: (2016)

Sparcl1 and Atherosclerosis
por: Cheng, Xu, et al.
Publicado: (2023)

Associations of tumor suppressor SPARCL1 with cancer progression and prognosis
por: Li, Ting, et al.
Publicado: (2017)

CHRDL1 Regulates Stemness in Glioma Stem-like Cells
por: Berglar, Inka, et al.
Publicado: (2022)

High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients
por: Chen, Yangshan, et al.
Publicado: (2019)

Disadvantages of a SPARCling defense
por: Bashyam, Hema
Publicado: (2008)

Prognostic value of SPARCL1 in patients with colorectal cancer
por: Han, Wei, et al.
Publicado: (2018)

Effects of SPARCL1 on the proliferation and differentiation of sheep preadipocytes
por: Xiao, Cheng, et al.
Publicado: (2021)

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
por: He, Kangwei, et al.
Publicado: (2022)

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
por: Cao, Zhongwei, et al.
Publicado: (2014)

Mutations in Hevin/Sparcl1 and risk of autism spectrum disorder
por: Taketomi, Takumi, et al.
Publicado: (2022)

Mechanisms of Regulation of the CHRDL1 Gene by the TWIST2 and ADD1/SREBP1c Transcription Factors
por: Casasnovas-Nieves, José J., et al.
Publicado: (2023)

Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer
por: Pei, Yao-fei, et al.
Publicado: (2017)

MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis
por: Yao, Guangyu, et al.
Publicado: (2013)

Association of CHRDL1 Mutations and Variants with X-linked Megalocornea, Neuhäuser Syndrome and Central Corneal Thickness
por: Davidson, Alice E., et al.
Publicado: (2014)

Correction: Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer
por: Pei, Yao-fei, et al.
Publicado: (2017)

Sparcle: assigning transcripts to cells in multiplexed images
por: Prabhakaran, Sandhya
Publicado: (2022)

Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2021)

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
por: Sun, Jingbo, et al.
Publicado: (2019)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients
por: Deng, Haifeng, et al.
Publicado: (2019)

Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with β-catenin and correlation with poor prognosis
por: Wang, Lei, et al.
Publicado: (2015)

Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer
por: Liu, Liya, et al.
Publicado: (2021)

Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling
por: Kuo, Sung-Hsin, et al.
Publicado: (2021)

Decreased expression of the Nkx2.8 gene correlates with tumor progression and a poor prognosis in HCC cancer
por: Qu, Lei, et al.
Publicado: (2014)

The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

Atorvastatin in stroke: a review of SPARCL and subgroup analysis
por: Huisa, Branko N, et al.
Publicado: (2010)

EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma
por: Deng, Mingming, et al.
Publicado: (2021)

High expression of Linc00959 predicts poor prognosis in breast cancer
por: Chi, Weiru, et al.
Publicado: (2019)

Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
por: Peng, Chen, et al.
Publicado: (2020)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

Long non-coding RNA LSAMP-1 is down-regulated in non-small cell lung cancer and predicts a poor prognosis
por: Gong, Wei, et al.
Publicado: (2022)

Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues
por: Klingler, Anika, et al.
Publicado: (2020)

SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer
por: Zhang, Hai-Ping, et al.
Publicado: (2022)

Identification of critical pathways and potential therapeutic targets in poorly differentiated duodenal papilla adenocarcinoma
por: Lu, Yuanxiang, et al.
Publicado: (2021)

Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study
por: Li, Jian-jun, et al.
Publicado: (2016)

Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
por: Gao, Chundi, et al.
Publicado: (2018)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lh1q5j0vtn3cnni2vnf1ctp0m6